Preparation of chitosan-plasinid DNA nanoparticles encoding zona pellucida glycoprotein-3α and its expression in mouse

被引:15
作者
Sun, CJ [1 ]
Pan, SP [1 ]
Xie, QX [1 ]
Xiao, LJ [1 ]
机构
[1] Jinan Univ, Coll Life Sci & Technol, Res Ctr Reproduct Immunol, Guangzhou 510632, Guangdong, Peoples R China
关键词
zona pellucida; chitosan; DNA vaccine; immunocontraception; nanoparticles;
D O I
10.1002/mrd.20058
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In the present study, the porcine zona pellucida (ZP)-3alpha eukaryotic expression vector pVAX1-pZP3alpha was constructed by genetic recombinant technology, then the recombinant plasmid was encapsulated in nanoparticles with chitosan, and the imaging of chitosan/pVAX1-pZP3alpha. nanoparticles by Atomic Force Microscope (AFM) was processed. Feeding mouse with those microencapsulation by gastric larvae, and after 5 days, detecting its expression in mouse intestine by RT-PCR and indirect immunofluorescence (IIF). Results show that the porcine ZP-3alpha. eukaryotic expression vector pVAX1-pZP3alpha had been constructed correctly, and the chitosan-DNA expressing ZP microencapsulation was prepared successfully. After 5 days of feeding mouse, the transcription and expression of those DNA vaccines were found in mouse alvine chorion. The preparation of chitosan/ pVAX1-pZP3alpha. plasmid DNA nanoparticles and its expression in mice will help to investigate the feasibility of ZP DNA vaccine to induce oviduct local mucosal immunity against ZP to block the fertilization without causing ovarian dysfunction, which will provide new ideas and ways for research and exploiting more effective, more convenient oral contraceptive vaccines. (C) 2004 Wiley-Liss, Inc.
引用
收藏
页码:182 / 188
页数:7
相关论文
共 26 条
[1]  
AITKEN RJ, 1996, AM J REPROD IMMUNOL, V35, P75
[2]   Targeted antigen delivery to antigen-presenting cells including dendritic cells by engineered Fas-mediated apoptosis [J].
Chattergoon, MA ;
Kim, JJ ;
Yang, JS ;
Robinson, TM ;
Lee, DJ ;
Dentchev, T ;
Wilson, DM ;
Ayyavoo, V ;
Weiner, DB .
NATURE BIOTECHNOLOGY, 2000, 18 (09) :974-979
[3]   DNA vaccines for viral diseases [J].
Davis, HL ;
McCluskie, MJ .
MICROBES AND INFECTION, 1999, 1 (01) :7-21
[4]   Nasal vaccines [J].
Davis, SS .
ADVANCED DRUG DELIVERY REVIEWS, 2001, 51 (1-3) :21-42
[5]   Distribution of DNA vaccines determines their immunogenicity after intramuscular injection in mice [J].
Dupuis, M ;
Denis-Mize, K ;
Woo, C ;
Goldbeck, C ;
Selby, MJ ;
Chen, MC ;
Otten, GR ;
Ulmer, JB ;
Donnelly, JJ ;
Ott, G ;
McDonald, DM .
JOURNAL OF IMMUNOLOGY, 2000, 165 (05) :2850-2858
[6]   DNA VACCINES - PROTECTIVE IMMUNIZATIONS BY PARENTERAL, MUCOSAL, AND GENE-GUN INOCULATIONS [J].
FYNAN, EF ;
WEBSTER, RG ;
FULLER, DH ;
HAYNES, JR ;
SANTORO, JC ;
ROBINSON, HL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (24) :11478-11482
[7]   Failure of female baboons (Papio anubis) to conceive following immunization with recombinant non-human primate zona pellucida glycoprotein-B expressed in Escherichia coli [J].
Govind, CK ;
Gupta, SK .
VACCINE, 2000, 18 (26) :2970-2978
[8]   ANTIFERTILITY EFFECT OF ACTIVE IMMUNIZATION WITH ZP4 GLYCOPROTEIN FAMILY OF PORCINE ZONA-PELLUCIDA IN HAMSTERS [J].
HASEGAWA, A ;
KOYAMA, K ;
INOUE, M ;
TAKEMURA, T ;
ISOJIMA, S .
JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 1992, 22 (02) :197-210
[9]  
Illum L, 1998, PHARM RES-DORDR, V15, P1326
[10]   Mechanism of cell transfection with plasmid/chitosan complexes [J].
Ishii, T ;
Okahata, Y ;
Sato, T .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2001, 1514 (01) :51-64